文献速递细胞病理与分子病理

台湾多中心研究:国际浆膜腔积液细胞病理报告系统对良恶性病因的综合评估

Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.
PubMed 文献 · Cancer Cytopathol · 2023-12-08

本研究回顾性分析台湾三家医院2018至2020年共6177例浆膜腔积液标本,按ISRSFC重新分类并计算恶性风险。结果显示各诊断类别ROM梯度明确,胸水MAL的ROM达95.1%,腹水MAL为92.3%,心包积液SFM为100.0%,证实ISRSFC诊断有用性。

要点

  • ISRSFC五分类在胸腹水中心包积液中均显示ROM梯度递增。
  • 胸水MAL的ROM为95.1%,腹水MAL为92.3%,心包积液SFM为100.0%。
  • 各积液最常见良恶性病因已揭示,有助临床分层管理。

核心结论

  • 多中心数据确定ISRSFC的诊断有用性,为病理医师和临床医师正确分类积液以进一步管理提供帮助。

研究设计与样本

  • 回顾性多中心研究,纳入台湾三家医院2018至2020年共6177例浆膜腔积液标本,按ISRSFC重新分类并行细胞组织学对照和病历回顾。

主要发现

  • 胸水4838例中ND 34例(0.7%)、NFM 4086例(84.5%)、AUS 201例(4.2%)、SFM 92例(1.9%)、MAL 425例(8.8%)。
  • 腹水1231例中ND 13例(1.1%)、NFM 1004例(81.6%)、AUS 53例(4.3%)、SFM 31例(2.5%)、MAL 130例(10.6%)。
  • 胸水ROM:ND 2.9%、NFM 14.0%、AUS 52.2%、SFM 85.9%、MAL 95.1%。
  • 腹水ROM:ND 15.4%、NFM 19.1%、AUS 52.8%、SFM 83.9%、MAL 92.3%。
  • 心包积液ROM:ND 0.0%、NFM 11.6%、AUS 30.8%、SFM 100.0%、MAL 95.2%。

关键数值与推荐

  • ISRSFC将浆膜腔积液分为ND、NFM、AUS、SFM、MAL五类。
  • 胸水MAL的ROM为95.1%,腹水MAL为92.3%,心包积液SFM为100.0%。

临床怎么用

  • 依据ISRSFC分类及对应ROM对积液标本进行风险分层,辅助临床进一步管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The International System for Reporting Serous Fluid Cytopathology (ISRSFC) was introduced globally in 2019 in response to the absence of a standardized reporting system for serous fluid cytology. This study presents experiences implementing this system across three distinct hospitals in Taiwan. METHODS: A total of 6177 serous fluid specimens in three hospitals in Taiwan between 2018 and 2020 were retrospectively reviewed and reclassified according to the ISRSFC. Cytohistological correlation and chart review were further performed to investigate etiologies and risks of malignancy (ROMs). RESULTS: Reclassification showed that 34 (0.7%) of 4838 pleural effusions were nondiagnostic (ND), 4086 (84.5%) were negative for malignancy (NFM), 201 (4.2%) were atypia of undetermined significance (AUS), 92 (1.9%) were suspicious for malignancy (SFM), and 425 (8.8%) were malignant (MAL). The 1231 ascites cases contained 13 (1.1%) ND, 1004 (81.6%) NFM, 53 (4.3%) AUS, 31 (2.5%) SFM, and 130 (10.6%) MAL specimens. In pleural effusions, the ROM was 2.9% for ND, 14.0% for NFM, 52.2% for AUS, 85.9% for SFM, and 95.1% for MAL. In ascites, it was 15.4% for ND, 19.1% for NFM, 52.8% for AUS, 83.9% for SFM, and 92.3% for MAL. In pericardial effusions, it was 0.0% for ND, 11.6% for NFM, 30.8% for AUS, 100.0% for SFM, and 95.2% for MAL. Different effusions' most common benign and malignant etiologies were also disclosed. CONCLUSIONS: These multi-institutional data have determined the diagnostic usefulness of the ISRSFC, which provides pathologists and physicians with invaluable assistance in correctly classifying effusions for further management.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Lu CH, Liu CY, Jhuang JY, et al. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan. Cancer Cytopathol. 2023. PMID: 38062987. doi:10.1002/cncy.22783

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。